Saturday, October 24, 2015
Travel and Lodging
Sign up for Email Updates
Invite a Colleague
More Live Events
Exhibit and Sponsor
Henry A. Nasrallah, MD
The Sydney W. Souers Professor and Chair
Department of Neurology and Psychiatry
Saint Louis University School of Medicine
St. Louis, Missouri
Dr. Henry Nasrallah is professor and chairman of the Department of Neurology and Psychiatry at Saint Louis University, and holds the Sydney W. Souers Endowed Chair. He is a widely recognized neuropsychiatrist, educator and researcher. Following his psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as chair of the Ohio State University Department of Psychiatry for twelve years. In January 2003, he joined the University of Cincinnati College of Medicine as Associate Dean and Professor of Psychiatry and Neuroscience. In October 2013, he joined St. Louis University to chair the integrated Department of Neurology and Psychiatry.
Dr. Nasrallah's research focuses on the neurobiology and psychopharmacology of schizophrenia and related psychoses. He has published 380 scientific articles, 440 abstracts, as well as 11 books. He is Editor-In-Chief of two journals (SCHIZOPHRENIA RESEARCH and CURRENT PSYCHIATRY) and is the co-founder of the Schizophrenia International Research Society (SIRS). He is board certified in in adult psychiatry. He is a fellow in the American College of Neurpsychopharmacology (ACNP) a distinguished fellow of the American Psychiatric Association (APA) , and has served as president of the Cincinnati Psychiatric Society and as president of the American Academy of Clinical Psychiatrists. He has twice received the NAMI Exemplary Psychiatrist Award and was chosen as the U.S.A. Teacher of the Year by the Psychiatric Times. He has received over 90 research grants and is listed in all editions of the book "Best Doctors in America".
Leslie Citrome, MD
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Leslie Citrome, MD, MPH, is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. He is a member of the Board of Directors of the American Society of Clinical Psychopharmacology and the Mental Health Association of Rockland County. Dr Citrome was the Founding Director of the Clinical Research and Evaluation Facility at the Nathan S Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly 2 decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr Citrome is now engaged as a consultant in clinical trial design and interpretation. He is a frequent lecturer on the quantitative assessment of clinical trial results using evidence-based medicine. Dr Citrome graduated from the McGill University Faculty of Medicine and completed a residency and chief residency in psychiatry at New York University. His primary research interests have centered on psychopharmacologic approaches to schizophrenia, bipolar disorder, major depressive disorder, the management of treatment-refractory schizophrenia, and the management of aggressive and violent behavior. Dr Citrome has authored or coauthored more than 400 research reports, reviews, chapters, and abstracts in the scientific literature. He serves as Editor-in-Chief for the International Journal of Clinical Practice and is on the editorial board of 9 other medical journals. He has lectured extensively throughout the United States, Canada, Europe, and Asia. Dr Citrome is the author of the book, Handbook of Treatment-Resistant Schizophrenia, published in 2013 by Springer Healthcare.
Paula J. Clayton, MD
Department of Psychiatry and Behavioral Sciences
University of New Mexico School of Medicine
Past Medical Director
American Foundation for Suicide Prevention
New York, NY
Paula J. Clayton, a native of St. Louis, received her undergraduate degree from the University of Michigan in 1956. She was one of four women to earn a medical degree from the Washington University School of Medicine in 1960. After an internship at St. Luke's Hospital, Clayton was a resident in Psychiatry at Barnes and Renard Hospitals in St. Louis, serving as chief resident in 1964-65. In 1965 Clayton was appointed an instructor in Psychiatry at Washington University. She was promoted to assistant professor in 1967, to associate professor in 1972, and finally to full professor in 1974.
An internationally recognized researcher in psychiatry, Clayton became known for her studies on mood disorders and bereavement. She was the first to define mania and schizoaffective disorders. In 1967 Clayton and her mentor, George Winokur, were the first Americans to describe the separation of mood disorders into unipolar and bipolar illnesses. In the late 1960s and early 1970s, Clayton published landmark research on the symptoms and normal course of bereavement. Clayton co-authored the first textbook on mania,
Manic Depressive Illness
, in 1969. Her publications to date include over 160 papers, three additional books, and 20 book chapters.
In 1980 Clayton left Washington University to head the Department of Psychiatry at the University of Minnesota School of Medicine, thus becoming the first woman to chair a department of psychiatry in the U.S. and the first woman to head a department in the medical school of the University of Minnesota. After almost 20 years in Minnesota, Clayton retired as professor emeritus of Psychiatry. She then joined the faculty of the University of New Mexico School of Medicine, where she is currently a professor of Psychiatry.
Dr. Clayton has been an active member and leader of many psychiatric societies, including the American Psychiatric Association and the American College of Neuropsychopharmacology. She has served as president of the Psychiatric Research Society (1977-78), the American Psychopathological Association (1981), and the Society of Biological Psychiatry (1986-87).
In 1985 Clayton received the Athena Award from the University of Michigan as the outstanding alumna of the year. That same year she received a Distinguished Alumnae Award from Washington University. Dr. Clayton received a Lifetime Research Award from the National Depressive and Manic Depressive Association. In 1993, Clayton was one of eight women honored with the Aphrodite Jannopoulo Hofsommer Award from Washington University.
Jason I. Dailey, MD, FAPA
Medical Corps, US Army
Commander, 212th Medical Detachment (COSC)
Fort Campbell, KY
Dr. Jason Dailey is a US Army psychiatrist, and currently serves as the Commander of the 212th Medical Detachment (Combat and Operational Stress Control) at Ft. Campbell, KY. He trained at UCLA and the University of Michigan Medical School prior to beginning active duty service with the US Army and completing his psychiatry residency at Tripler Army Medical Center, Hawaii. He is a board-certified Diplomat of the American Board of Psychiatry and Neurology and a Fellow of the American Psychiatric Association.
Dr. Dailey is also a combat veteran having deployed to Afghanistan as the Command Psychiatrist for Regional Command- East, Afghanistan. As the Division Psychiatrist for the 101st Airborne Division (Air Assault) he was responsible for the supervision and mentorship of psychologists and social workers throughout the Division, and regularly lectured primary care physicians and mid-level providers on psychotropic prescribing. His unique experience as both the Commander of a deployable psychiatric unit and as a staff officer in charge of behavioral health care for eastern Afghanistan makes him one of the US Army's top subject matter experts in the provision of psychiatric services in a combat zone. His military decorations include the Meritorious Service Medal, the Army Commendation Medal, the Army Achievement Medal, and the Air Assault Badge.
Marlene Freeman, MD
Associate Professor of Psychiatry, Harvard Medical School
Medical Director, CTNI
Director of Clinical Services, Perinatal and Reproductive
Massachusetts General Hospital
Marlene P. Freeman, MD is an Associate Professor of Psychiatry, Harvard Medical School.
She is the Director of Clinical Services, Perinatal and Reproductive Psychiatry Program at Massachusetts General Hospital and the Medical Director of the MGH Clinical Trials Network and Institute.
Dr. Freeman completed medical school at Northwestern University Medical School. She completed residency at the Harvard Longwood Psychiatry Residency Program and a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine. Her research and clinical expertise is in the areas of mood disorders and women's mental health. She previously established and directed Women's Mental Health Programs at the University of Arizona and the University of Texas Southwestern Medical Center. She is the Director of Clinical Services at the MGH Center for Women's Mental Health, Perinatal and Reproductive Psychiatry. She is Vice Editor-in-Chief for The Journal of Clinical Psychiatry. She is a Distinguished Fellow of the American Psychiatric Association (APA), and chaired the APA Task Force on Complementary and Alternative Medicine, subcommittee on Omega-3 Fatty Acids in Psychiatry, and was a member of the APA's workgroup on Major Depressive Disorder treatment guidelines. She is on the Board of Directors of the American Society of Clinical Psychopharmacology (ASCP) and Postpartum Progress, Inc., and is a Member of the American College of Neuropsychopharmacology (ACNP). She is a Member of the Veterans Administration Reproductive Mental Health Steering Committee.
Jeffrey R. Strawn, MD,FAACAP
Associate Professor of Psychiatry
Director, Anxiety Disorders Research Program
Department of Psychiatry & Behavioral Neuroscience
University of Cincinnati
Dr. Strawn is an Associate Professor of Psychiatry at the University of Cincinnati and at Cincinnati Children’s Hospital and Director of the Anxiety Disorders Research Program. He completed general psychiatry residency training at the University of Cincinnati and a clinical fellowship in child and adolescent psychiatry at Cincinnati Children’s Hospital.
His current research involves clinical trials in youth with mood and anxiety disorders as well as the identification of risk factors for these conditions. Additionally, his research focuses on the pathophysiology and psychopharmacology of these conditions. More recently, Dr. Strawn has extended his research related to evidence-based treatments for mood and anxiety disorders in youth and the neurobiologic basis of these disorders, to include the elucidation of neurofunctional and neurochemical biomarkers of treatment response.
Dr. Strawn has authored some 80 peer-reviewed publications and has co-authored two books on the treatment of children and adolescents and on contemporary psychotherapy. He is a fellow of the American Psychiatric Association, a distinguished fellow of the American Academy of Child & Adolescent Psychiatry, a member of the Anxiety Disorders Association of America and has been elected to Alpha Omega Alpha. Additionally, he is the recipient of numerous awards for teaching and research.
Rajiv Tandon, MD
Chief of Psychiatry
Program of Mental Health
State of Florida Department of Children and Families
Rajiv Tandon, MD, is currently a Professor of Psychiatry at the University of Florida College of Medicine in Gainesville, Florida. Since 2000, he has been a member of the Scientific Council of the National Alliance for the Mentally Ill and he is currently the President of the Florida chapter of the National Alliance for Mental Illness. Dr. Tandon has authored more than 250 scientific publications, and given over 800 national and international scientific presentations. He has received several awards for research and teaching in schizophrenia, including the American Psychiatric Association Young Psychiatrist of the Year award in 1993 and the 1997 FuturPsych award for outstanding achievement in schizophrenia research. He has been included in every edition of THE BEST DOCTORS IN AMERICA since 1995. He received the Exemplary Psychiatrist Award from the National Alliance for Mental Illness in 2009, 2012, and 2015. He was a member of the DSM-5 workgroup on schizophrenia and related psychotic disorders and is a member of the World Psychiatry Association Pharmacopsychiatry Section. His major areas of clinical and research interest are the neuropharmacology of schizophrenia, differences between typical and atypical antipsychotic agents, dimensions of schizophrenic psychopathology (with a particular focus on negative symptoms), neuroendocrine and polysomnographic abnormalities in schizophrenia, and the evidence-based treatment of schizophrenia and other major mental disorders.
Copyright 2015 University of Cincinnati
Invite a Colleague
Sign Up for Email Updates